Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SonoCareLab is a South Korean medical technology company specializing in the development of advanced ultrasound-mediated drug delivery systems (UDDS) and therapeutic ultrasound devices. The company leverages its proprietary platform to enhance the permeability of biological barriers, such as the blood-brain barrier and skin, allowing for more effective delivery of therapeutic agents. Their portfolio includes high-intensity focused ultrasound (HIFU) technology and microbubble-based delivery mechanisms aimed at treating oncology and neurological disorders. SonoCareLab aims to bridge the gap between traditional drug therapy and precision medical devices to improve patient outcomes in complex disease areas. The company operates as a spin-off from the Daegu Gyeongbuk Institute of Science and Technology (DGIST).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SONOCARELAB.